Inflammatory Bowel Disease Induces Colorectal Cancer: Risk Factors, Triggering Mechanisms, and Treatment With Phyto‐Derivatives
Phytotherapy Research · 2025
DOI: 10.1002/ptr.70015 ↗At a glance
Übersichtsarbeit in Phytotherapy Research, 2025. Written by Yuyu Zhang and 12 co-authors. Institution: College of Food and Bioengineering, Xihua University, Chengdu, China. Major MEDLINE topics: Inflammatory Bowel Diseases, Colorectal Neoplasms, Phytochemicals, Colitis-Associated Neoplasms. Cited 9 times so far (Crossref); 296 references. Funded by: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Key Research and Development Project of Liangshan Prefecture.
Abstract (original language)
Colorectal cancer (CRC), one of the most prevalent malignant neoplasms, ranks as a leading cause of cancer‐related mortality on a global scale. A particularly aggressive variant of CRC is colitis‐associated colon cancer (CAC). Patients with chronic inflammatory bowel disease (IBD) are at increased risk for CAC. The pathogenesis of CAC is influenced by numerous factors and is highly complex. Due to the complexity of the mechanism by which chronic inflammation of the intestine leads to the transformation of colorectal cancer, there is currently no standardized strategy for the advance prophylaxis of CAC. Significantly, phyto‐derivatives exhibit significant potential in the prevention of CAC. Currently, researches have demonstrated that natural products extracted from plants including polyphenols, alkaloids, saponins, terpenoids, polysaccharides, and plant extracellular vesicles can achieve significant anti‐inflammatory, antioxidant, and gut microbiota regulating activities through oral administration. It is a valuable opportunity for the application of natural products in chronic intestinal inflammation to inhibit the transformation of intestinal inflammation into malignancy. In this review, we provide a comprehensive analysis of the predisposing factors and pathogenesis of CAC, along with the mechanisms through which various plant‐derived compounds inhibit CAC development. This work aims to provide innovative and practical treatment strategies for the prevention of CAC.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- College of Food and Bioengineering, Xihua University, Chengdu, China.
- Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- College of Comprehensive Health Management, Xihua University, Chengdu, China.
- Institute of Molecular Medicine (IMM), Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
ORCID profiles: Yuyu Zhang, Yuxin He, Zhejie Chen, Ling Li
Funding
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Key Research and Development Project of Liangshan Prefecture
- Central Nervous System Drug Key Laboratory of Sichuan Province
- International Hong Kong, Macao and Taiwan Science and Technology Innovation Cooperation Project, Science and Technology Department of Sichuan Province
Cite
APA
Zhang, Y., Zhang, Y., Yao, S., Chen, L., Dong, Q., Luo, R., Zheng, K., Liu, J., Liu, Y., Chen, Y., He, Y., Chen, Z., & Li, L. (2025). Inflammatory Bowel Disease Induces Colorectal Cancer: Risk Factors, Triggering Mechanisms, and Treatment With Phyto‐Derivatives. Phytotherapy Research. https://doi.org/10.1002/ptr.70015
Vancouver
Zhang Y, Zhang Y, Yao S, Chen L, Dong Q, Luo R, et al. Inflammatory Bowel Disease Induces Colorectal Cancer: Risk Factors, Triggering Mechanisms, and Treatment With Phyto‐Derivatives. Phytotherapy Research. 2025. doi:10.1002/ptr.70015
BibTeX
@article{Zhang2025,
author = {Zhang, Yuyu and Zhang, Yi and Yao, Shiyi and Chen, Liping and Dong, Qin and Luo, Ranwen and Zheng, Kaiyue and Liu, Jing and Liu, Yiming and Chen, Yutong and He, Yuxin and Chen, Zhejie and Li, Ling},
title = {Inflammatory Bowel Disease Induces Colorectal Cancer: Risk Factors, Triggering Mechanisms, and Treatment With Phyto‐Derivatives},
journal = {Phytotherapy Research},
year = {2025},
doi = {10.1002/ptr.70015}
}
EUVIMED